PT87702A - PROCESS FOR PREPARING AXAZOLIDIN-2-ONE DERIVATIVES USEFUL AS HYPOGLYCEMIC AGENTS - Google Patents

PROCESS FOR PREPARING AXAZOLIDIN-2-ONE DERIVATIVES USEFUL AS HYPOGLYCEMIC AGENTS

Info

Publication number
PT87702A
PT87702A PT87702A PT8770288A PT87702A PT 87702 A PT87702 A PT 87702A PT 87702 A PT87702 A PT 87702A PT 8770288 A PT8770288 A PT 8770288A PT 87702 A PT87702 A PT 87702A
Authority
PT
Portugal
Prior art keywords
axazolidin
preparing
pharmaceutically
derivatives useful
hypoglycemic agents
Prior art date
Application number
PT87702A
Other languages
Portuguese (pt)
Other versions
PT87702B (en
Inventor
David Alan Clark
Michael Ross Johnson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT87702A publication Critical patent/PT87702A/en
Publication of PT87702B publication Critical patent/PT87702B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Oxazolidin-2-one derivs. of formula (I), corresp. pharmaceutically-acceptable acid addn. salt or pharmaceutically-acceptable cationic salt are new. Rb is (i), (ii) (iii) or (iv), W is S or O; X, X' is H, Cl, F or CF3; Y is -COOR1, -CON(R1)CH2CONR3R3, gp. (v) or vi), Ra, R1, R2, R3 are H, CH3, R4 is CH3 or CF3. For pharmaceutically-acceptable acid addn. salt, Y is gp. (v) or Rb is gp. (iii). For pharmaceutically-acceptable cationic salt y is -COOH or gp. (vi). - Also claimed is an optically active cpd. of formula (I) and use of cpd. (I) as a medicament for the treatment of hyperglycemia.
PT87702A 1987-06-10 1988-06-09 PROCESS FOR THE PREPARATION OF UXO OXAZOLIDIN-2-ONA DERIVATIVES AS HYPOGLYCEMIC AGENTS PT87702B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/001356 WO1988009661A1 (en) 1987-06-10 1987-06-10 Oxazolidin-2-one derivatives as hypoglycemic agents

Publications (2)

Publication Number Publication Date
PT87702A true PT87702A (en) 1988-07-01
PT87702B PT87702B (en) 1992-10-30

Family

ID=22202413

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87702A PT87702B (en) 1987-06-10 1988-06-09 PROCESS FOR THE PREPARATION OF UXO OXAZOLIDIN-2-ONA DERIVATIVES AS HYPOGLYCEMIC AGENTS

Country Status (21)

Country Link
US (1) US4968707A (en)
EP (1) EP0294995B1 (en)
JP (1) JPS649979A (en)
KR (1) KR900007313B1 (en)
AT (1) ATE82284T1 (en)
AU (1) AU585196B2 (en)
CA (1) CA1305152C (en)
DE (1) DE3875806T2 (en)
DK (1) DK313588A (en)
ES (1) ES2045116T3 (en)
FI (1) FI89479C (en)
GR (1) GR3007059T3 (en)
HU (1) HU203330B (en)
IE (1) IE62029B1 (en)
IL (1) IL86603A (en)
MY (1) MY103297A (en)
NO (1) NO171978C (en)
NZ (1) NZ224957A (en)
PT (1) PT87702B (en)
WO (1) WO1988009661A1 (en)
ZA (1) ZA884114B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02167224A (en) * 1988-09-13 1990-06-27 Tanabe Seiyaku Co Ltd Antilipemic agent
US5356908A (en) * 1989-04-21 1994-10-18 E. I. Du Pont De Nemours And Company Fungicidal oxazolidinones
WO1991003474A1 (en) * 1989-08-29 1991-03-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5068342A (en) * 1989-10-27 1991-11-26 American Home Products Corporation 5-[(1- and 2-naphthalenyl)thio and sulfonyl]-2,4-thiazolidinediones and derivatives thereof
CA2083891A1 (en) * 1991-12-03 1993-06-04 Angus Murray Macleod Heterocyclic compounds, compositions containing them and their use in therapy
UA27467C2 (en) * 1992-04-07 2000-09-15 Пфайзер Інк. Indole derivatives as 5-ht1 agonists and intermediates
ATE185564T1 (en) * 1992-08-31 1999-10-15 Sankyo Co OXAZOLIDINE DERIVATIVES HAVING ANTIDIABETIC AND ANTI-OBESITY PROPERTIES, THEIR PREPARATION AND THERAPEUTIC USE
KR0173145B1 (en) * 1993-04-07 1999-02-01 고바야시 유키오 Thiazolidine derivative and pharmaceutical composition containing the same
US5629200A (en) * 1993-11-18 1997-05-13 Daicel Chemical Industries, Ltd. Production of optically active 2-amino-1-phenylethanol derivatives by asymetrical assimilation
CA2145257A1 (en) * 1994-03-23 1995-09-24 Takashi Fujita Thiazolidine and oxazolidine derivatives, their preparation and their medical use
ES2421511T3 (en) 2001-12-21 2013-09-03 X Ceptor Therapeutics Inc LXR modulators
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
DOP2005000123A (en) * 2004-07-02 2011-07-15 Merck Sharp & Dohme CETP INHIBITORS
ES2324794T3 (en) * 2004-12-21 2009-08-14 Gilead Sciences Inc IMIDAZO (4,5-C) COMPONENT PYRIDINE AND ANTIVIRAL TREATMENT METHOD.
AR057218A1 (en) * 2005-12-15 2007-11-21 Astra Ab OXAZOLIDINONE COMPOUNDS AND THEIR USE AS PONTENCIATORS OF THE METABOTROPIC GLUTAMATE RECEIVER
EP2029560B1 (en) 2005-12-30 2013-04-24 Merck Sharp & Dohme Corp. 1,3-oxazolidin-2-one derivatives useeful as cetp inhibitors

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909467A (en) * 1958-07-09 1959-10-20 Us Vitamin Pharm Corp 3-(d-alpha-methylphenethyl)-5-methyl-1, 3-oxazolidine-2, 4-dione
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
DD153682A1 (en) * 1978-10-19 1982-01-27 Horst Bercher PROCESS FOR PRODUCING NEW ALKANOLAMINE
DE3162756D1 (en) * 1980-05-22 1984-04-26 Beecham Group Plc Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions
SG56656G (en) * 1980-07-28 1987-03-27 Pfizer Hypoglycemic 5-substituted oxazolidine-2, 4-diones
US4407811A (en) * 1981-01-02 1983-10-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
ES8400116A1 (en) * 1981-10-13 1983-10-16 Pfizer Oxazolidinedione derivatives.
GR78120B (en) * 1982-03-01 1984-09-26 Pfizer
JPS58183676A (en) * 1982-04-19 1983-10-26 Takeda Chem Ind Ltd Oxazole derivative
US4430337A (en) * 1982-06-23 1984-02-07 Pfizer Inc. Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
US4617312A (en) * 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones
DE3476386D1 (en) * 1983-11-02 1989-03-02 Beecham Group Plc MORPHOLINE DERIVATIVES
EP0142102B1 (en) * 1983-11-04 1987-09-23 Beecham Group Plc Tertiary amines
CA1249992A (en) * 1983-11-10 1989-02-14 Marcel Muller Oxazolidines
GB8412862D0 (en) * 1984-05-19 1984-06-27 Beecham Group Plc Compounds
GB8418657D0 (en) * 1984-07-21 1984-08-22 Beecham Group Plc Compounds
WO1986002073A1 (en) * 1984-10-03 1986-04-10 Takeda Chemical Industries, Ltd. Thiazolidinedione derivatives, process for their preparation, and pharmaceutical composition containing same
DE3438839A1 (en) * 1984-10-19 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen PHARMACEUTICAL PREPARATIONS
AR240698A1 (en) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Process for the preparation of 5-(4-(2-(5-ethyl-2-pyridil)-ethoxy)benzyl)-2,4-thiazolodinedione and their salts
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones
JPH06779B2 (en) * 1985-06-10 1994-01-05 武田薬品工業株式会社 Thiazolidione derivative and pharmaceutical composition comprising the same
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4873255A (en) * 1987-02-04 1989-10-10 Sankyo Company Limited Thiazolidinone derivatives, their preparation and their use
EP0295828A1 (en) * 1987-06-13 1988-12-21 Beecham Group Plc Novel compounds
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents

Also Published As

Publication number Publication date
FI895815A0 (en) 1989-12-05
DE3875806T2 (en) 1993-04-08
EP0294995B1 (en) 1992-11-11
KR900007313B1 (en) 1990-10-08
GR3007059T3 (en) 1993-07-30
NO171978C (en) 1993-05-26
IL86603A (en) 1992-09-06
MY103297A (en) 1993-05-29
NO890529D0 (en) 1989-02-08
WO1988009661A1 (en) 1988-12-15
HU203330B (en) 1991-07-29
ZA884114B (en) 1990-02-28
HUT53623A (en) 1990-11-28
DE3875806D1 (en) 1992-12-17
FI89479C (en) 1993-10-11
US4968707A (en) 1990-11-06
KR890000447A (en) 1989-03-14
NO171978B (en) 1993-02-15
DK313588D0 (en) 1988-06-09
PT87702B (en) 1992-10-30
ES2045116T3 (en) 1994-01-16
FI89479B (en) 1993-06-30
AU1753488A (en) 1988-12-15
NZ224957A (en) 1990-03-27
IL86603A0 (en) 1988-11-30
DK313588A (en) 1989-02-10
EP0294995A1 (en) 1988-12-14
IE881734L (en) 1988-12-10
JPS649979A (en) 1989-01-13
NO890529L (en) 1989-02-08
CA1305152C (en) 1992-07-14
ATE82284T1 (en) 1992-11-15
AU585196B2 (en) 1989-06-08
JPH0448791B2 (en) 1992-08-07
IE62029B1 (en) 1994-12-14

Similar Documents

Publication Publication Date Title
PT87702A (en) PROCESS FOR PREPARING AXAZOLIDIN-2-ONE DERIVATIVES USEFUL AS HYPOGLYCEMIC AGENTS
NO166448C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIAZOLIDE INDIANS.
FI902258A0 (en) Process for the preparation of pharmacologically active 13,14-dihydro-17-phenyl-18,19,20-trinor-PGF2 alkyl esters
ES2044878T3 (en) A PROCESS FOR THE PREPARATION OF BENZIMIDAZOLE DERIVATIVES.
FI922850A0 (en) Process for preparing a virus inactivated blood product
HUT57044A (en) Process for producing phrmaceutical compositions having n-neuropeptide antagonistic effect and comprising imidazolyl alkylguanidine derivatives
DE3873578D1 (en) USE OF TETRAHYDROBENZ (C, D) INDOL-6-CARBOXAMIDES FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF ANXIETIES.
SE8704979D0 (en) NEW FURANURONIC ACID DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
ATE181503T1 (en) USE OF IDAZOXAN AND DERIVATIVES FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF PARKINSONISM AND ITS EVOLUTION
DK149492C (en) ANALOGY PROCEDURE FOR PREPARING 3-ALKYLTHIO-2-ACYLOXYPROPYL-2'-TRIMETHYL-AMMONIOETHYL-PHOSPHATES
PT96828A (en) METHOD FOR PREPARING AN AGENT FOR DIABETIC GANGRENA THERAPY CONTAINING BLOOD COAGULATION FACTOR XIII
ATE212842T1 (en) QUINOXALINE DERIVATIVES FOR THE TREATMENT OF TINNITUS
KR900004730A (en) 4- [4- (3-benzisothiazolyl) -1-piperazinyl] butyl crosslinked bicyclic imide as an antipsychotic
HUT45989A (en) Process for production of derivatives of 1,4-dihydropiridine and medical preparatives containing them as active substance
ATE66811T1 (en) APPLICATION OF N-((1-AETHYL-2-PYRROLIDINYL)METHYL>METHOXY-5-SULFAMOYLBENZAMIDE FOR STERILITY TREATMENT.
ATE81465T1 (en) USE OF 2-OXO-IMIDAZOLIDINE DERIVATIVES IN THE TREATMENT OF KIDNEY DISEASES.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920401

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19971031